
Adopting a low-to-moderate risk posture, researchers are proceeding with targeted validation of epigenetic biomarkers despite an Expression of Concern that has raised some alarms. The evidence indicates that epigenetic alterations are consistently tied to various health issues, from traumatic brain injury to cancer progression, while foundational studies continue to support their role as both biomarkers and therapeutic targets. Cross-laboratory replication and transparent data practices will be prioritized to ensure robust findings.

Title not available for this citation.
“We investigated genome-wide DNA methylation changes induced by chronic risperidone administration in the common marmoset, a non-human primate with high translational relevance. Adult males were treated orally with risperidone for 28 days.”

Title not available for this citation.
“Emerging evidence indicates that epigenetic and epitranscriptomic mechanisms, including histone modifications, DNA methylation, and RNA modifications, play pivotal roles in the molecular response to TBI.”

Title not available for this citation.
“the authors were contacted by the Editorial Office to offer an explanation for this apparent anomaly in the presentation of the data in this paper; however, up to this time, no response from them has been forthcoming.”

Title not available for this citation.
“Pharmacological inhibition of DNA methyltransferases (SGI-1027) or ferroptosis (ferrostatin-1) significantly ameliorated renal injury.”